Starton Therapeutics (Starton Therapeutics) Other Stockholders Equity : $2.94 Mil (As of Jun. 2023)

View and export this data going back to 2050. Start your Free Trial

What is Starton Therapeutics Other Stockholders Equity?

Starton Therapeutics's Other Stockholders Equity for the quarter that ended in Jun. 2023 was $2.94 Mil.

Starton Therapeutics's quarterly Other Stockholders Equity declined from Dec. 2022 ($3.23 Mil) to Mar. 2023 ($0.23 Mil) but then increased from Mar. 2023 ($0.23 Mil) to Jun. 2023 ($2.94 Mil).

Starton Therapeutics's annual Other Stockholders Equity increased from Mar. 2021 ($0.04 Mil) to Mar. 2022 ($0.42 Mil) but then declined from Mar. 2022 ($0.42 Mil) to Mar. 2023 ($0.23 Mil).

Starton Therapeutics Other Stockholders Equity Historical Data

The historical data trend for Starton Therapeutics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starton Therapeutics Other Stockholders Equity Chart

Starton Therapeutics Annual Data

Trend

Mar21

Mar22

Mar23

Other Stockholders Equity

0.04

0.42

0.23

Starton Therapeutics Quarterly Data
	Mar21	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23
Other Stockholders Equity	Get a 7-Day Free Trial			0.42	-	3.23	0.23	2.94

Starton Therapeutics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Starton Therapeutics Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Starton Therapeutics's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Starton Therapeutics (Starton Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starton Therapeutics Inc (NAS:STA) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

215 College Road, Suite No.300, Paramus, NJ, USA, 07652

Website

https://www.startontx.com

Starton Therapeutics Inc is a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technology, so people with cancer can receive continuous treatment to live better, and longer. Starton's proprietary continuous delivery technology can increase the efficacy of approved drugs, make them more tolerable, and expand their potential use.

Starton Therapeutics (Starton Therapeutics) Headlines

No Headlines